Enzymit
Ness Ziona
About Enzymit
Enzymit's vision is to transform global manufacturing by eliminating dependence on scarce resources through local, sustainable, affordable bio-production. Enzymit is developing cell-free bio-production, the next generation of bio production technology eliminating the inefficiencies, complexity and cost of current bio-production technologies. Enzymit’s small, modular bio-reactors can efficiently convert available and abundant feedstocks into valuable products, from pharmaceuticals and cosmetics to food and materials. We are offering global resource independence while reducing the environmental impact. Enzymit uses artificial intelligence to design new-to-nature enzymes, the molecular machines in living cells that perform life-enabling functions. Our novel enzymes create molecular assembly lines that transform any feedstock into desired products. This approach reimagines bio-production by moving away from traditional, complex, and costly whole-cell methods to using nature’s elemental building blocks, making bio-production competitive with traditional chemical manufacturing in cost, efficiency, and sustainability, while also offering greater flexibility in product customization.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2024)
- Website: enzymit.com
- Phone: 972-50-422-2987
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/enzymit-105900 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.